Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

Phenylephrine is a medication that’s been used to relieve nasal congestion caused by colds, allergies, and hay fever, per the ...

Since Permatan doesn’t rely on the same controversial active ingredient as nasal sprays, it is considered to be safer in ...

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

ALK has a market cap of $36.8bn. Neffy became the first and only approved nasal spray medicine to treat severe allergic ...

The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected ... “ALK is a specialized pharmaceutical company and a global leader in the allergy field, serving ...

Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...

From soothing tea to noise-cancelling earplugs and calming lavender sprays, TBS listed a series of products for insomnia patients ...